The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO 2022 | Remaining areas of unmet need for patients with locally advanced pancreatic cancer
Rainer Fietkau, MD, PhD, University Hospital Erlangen, Erlangen, Germany, talks on the unmet needs of patients with locally advanced pancreatic cancer. 1/3 of this patient population will get distant metastases during induction chemotherapy, presenting a significant area for improvement. Prof. Rainer emphasizes the importance of obtaining an R0 resection for long-term survival and improving the selection criteria for patients undergoing surgery. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.
